Vizeum Sydney set to lose 70% of billings

Tim Burrowes

March 22, 2010 1:15

Aegis Media’s fledgling Vizeum Sydney office is set to lose 70 per cent of its annualised billings before the end of the year when it loses its key client pharmaceutical company, Bayer Healthcare, to Mindshare.

Bayer, maker of Berocca and Rennie, is moving its media planning and buying account into the WPP-owned agency following a review of the business in markets including Australia.

Kim Raicevich, Vizeum Sydney managing director, told Mumbrella: “We’ll definitely need to replace those billings which is a sizable chunk of our business. We’re always pitching and this will now give us an opportunity to look into the pharmaceutical area which is good.”

The Sydney office, which opened in the middle of last year has a staff of seven. Raicevich said there would be no staff cuts as a result of the loss of the Bayer business, which is expected to occur at the end of the third quarter.

Be a member to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Become a member

Tim Burrowes

Tim Burrowes is the publisher of Mumbrella and Unmade. He co-founded Mumbrella in 2008 and sister title Unmade in 2021. He's worked in the UK, Middle East, Asia & Australia and has specialised in writing about the communications world for the last 25 years. He wrote the book Media Unmade, published in 2021, and became the presenter of MediaLand on ABC Radio National in 2025.